Despite the success of CAR-T therapies for B-cell cancers and multiple myeloma, developing CAR-T therapies for solid tumors has posed more of a challenge. Failure of the CAR-T cells to multiply to high enough levels, the tumor microenvironment being immunosuppressive, and tumor cells ‘escaping’ the therapy by losing target antigen expression are just some of […]

Commercial-stage medical technology company Laboratory for Advanced Medicine (LAM) announced positive results from a new study that evaluated DNA methylation-based marker panel for early diagnosis of nasopharyngeal carcinoma (NPC). The data will be presented in an online only abstract as part of the annual meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago, Ill., May […]